{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T01:47:35Z","timestamp":1793065655951,"version":"4.5.0"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82030107"],"award-info":[{"award-number":["82030107"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82373944"],"award-info":[{"award-number":["82373944"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.jconrel.2025.114571","type":"journal-article","created":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T16:16:43Z","timestamp":1766420203000},"page":"114571","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Deciphering the in vivo fate and biomacromolecular interactions of DSPE-PEG2000"],"prefix":"10.1016","volume":"390","author":[{"given":"Deqi","family":"Cai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chong","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingze","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingkai","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jconrel.2025.114571_bb0005","article-title":"Thirty years from FDA approval of Pegylated liposomal doxorubicin (Doxil\/Caelyx): an updated analysis and future perspective","volume":"4","author":"Gabizon","year":"2025","journal-title":"BMJ Oncol."},{"issue":"2","key":"10.1016\/j.jconrel.2025.114571_bb0010","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jconrel.2012.03.020","article-title":"Doxil\u00ae \u2014 the first FDA-approved nano-drug: lessons learned","volume":"160","author":"Barenholz","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.114571_bb0015","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jconrel.2022.09.002","article-title":"Stealth nanoparticles in oncology: facing the PEG dilemma","volume":"351","author":"Zalba","year":"2022","journal-title":"J. Control. Release"},{"issue":"10","key":"10.1016\/j.jconrel.2025.114571_bb0020","doi-asserted-by":"crossref","first-page":"4277","DOI":"10.1021\/acsabm.3c00478","article-title":"Fluorescence lifetime nanoscopy of liposomal irinotecan Onivyde: from manufacturing to intracellular processing","volume":"6","author":"Bernardi","year":"2023","journal-title":"ACS Appl. Bio Mater."},{"key":"10.1016\/j.jconrel.2025.114571_bb0025","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.jconrel.2022.05.063","article-title":"Strategies for persistent retention of macromolecules and nanoparticles in the blood circulation","volume":"350","author":"Takakura","year":"2022","journal-title":"J. Control. Release"},{"issue":"12","key":"10.1016\/j.jconrel.2025.114571_bb0030","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.2174\/1381612821666150115144003","article-title":"DSPE-PEG: a distinctive component in drug delivery system","volume":"21","author":"Che","year":"2015","journal-title":"CPD"},{"key":"10.1016\/j.jconrel.2025.114571_bb0035","doi-asserted-by":"crossref","first-page":"4185","DOI":"10.2147\/IJN.S34489","article-title":"Application of poly(ethylene glycol)\u2013Distearoylphosphatidylethanolamine (PEG-DSPE) block copolymers and their derivatives as nanomaterials in drug delivery","author":"Xiao","year":"2012","journal-title":"IJN"},{"key":"10.1016\/j.jconrel.2025.114571_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.114079","article-title":"To PEGylate or not to PEGylate: immunological properties of nanomedicine\u2019s most popular component, polyethylene glycol and its alternatives","volume":"180","author":"Shi","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2025.114571_bb0045","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jconrel.2022.05.055","article-title":"Artificial engineering of the protein Corona at bio-nano interfaces for improved cancer-targeted nanotherapy","volume":"348","author":"Khan","year":"2022","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.jconrel.2025.114571_bb0050","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1080\/14686996.2016.1240006","article-title":"Interaction of poly(ethylene glycol)-conjugated phospholipids with supported lipid membranes and their influence on protein adsorption","volume":"17","author":"Yamamoto","year":"2016","journal-title":"Sci. Technol. Adv. Mater."},{"issue":"8","key":"10.1016\/j.jconrel.2025.114571_bb0055","doi-asserted-by":"crossref","first-page":"771","DOI":"10.3390\/jpm11080771","article-title":"The enhanced permeability and retention (EPR) effect: the significance of the concept and methods to enhance its application","volume":"11","author":"Wu","year":"2021","journal-title":"J. Pers. Med."},{"issue":"1","key":"10.1016\/j.jconrel.2025.114571_bb0065","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/cncr.22739","article-title":"Antibody against poly(ethylene glycol) adversely affects PEG-asparaginase therapy in acute lymphoblastic Leukemia patients","volume":"110","author":"Armstrong","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.jconrel.2025.114571_bb0070","series-title":"PEGylation of Proteins: A Structural Approach","first-page":"19","author":"Schrimsher","year":"2006"},{"key":"10.1016\/j.jconrel.2025.114571_bb0075","series-title":"Poly(Ethylene Glycol) Chemistry: Biotechnical and Biomedical Applications","year":"2025"},{"key":"10.1016\/j.jconrel.2025.114571_bb0080","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.addr.2020.07.024","article-title":"Anti-PEG antibodies: properties, formation, testing and role in adverse immune reactions to PEGylated Nano-biopharmaceuticals","volume":"154\u2013155","author":"Kozma","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2025.114571_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2023.115044","article-title":"The interplay between PEGylated nanoparticles and blood immune system","volume":"200","author":"Guo","year":"2023","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"8","key":"10.1016\/j.jconrel.2025.114571_bb0090","doi-asserted-by":"crossref","first-page":"9315","DOI":"10.1021\/acsnano.9b03942","article-title":"Pseudo-anaphylaxis to polyethylene glycol (PEG)-coated liposomes: roles of anti-PEG IgM and complement activation in a porcine model of human infusion reactions","volume":"13","author":"Kozma","year":"2019","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2025.114571_bb0095","doi-asserted-by":"crossref","DOI":"10.1021\/acsnano.1c05922","article-title":"Polyethylene glycol immunogenicity: theoretical, clinical, and practical aspects of anti-polyethylene glycol antibodies","author":"Chen","year":"2021","journal-title":"ACS Nano"},{"issue":"1","key":"10.1016\/j.jconrel.2025.114571_bb0100","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1124\/dmd.106.012419","article-title":"PEGylated proteins: evaluation of their safety in the absence of definitive metabolism studies","volume":"35","author":"Webster","year":"2007","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.jconrel.2025.114571_bb0105","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.toxlet.2022.01.011","article-title":"Toxicity of high-molecular-weight polyethylene glycols in Sprague Dawley rats","volume":"359","author":"Fang","year":"2022","journal-title":"Toxicol. Lett."},{"issue":"7","key":"10.1016\/j.jconrel.2025.114571_bb0110","doi-asserted-by":"crossref","first-page":"3156","DOI":"10.1016\/j.apsb.2022.01.014","article-title":"Biological fate and interaction with cytochromes P450 of the nanocarrier material, d-\u03b1-Tocopheryl polyethylene glycol 1000 succinate","volume":"12","author":"Ren","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"issue":"21","key":"10.1016\/j.jconrel.2025.114571_bb0115","doi-asserted-by":"crossref","first-page":"8224","DOI":"10.3390\/ijms21218224","article-title":"Pharmaceutical excipients and Drug metabolism: a mini-review","volume":"21","author":"Patel","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2025.114571_bb0120","author":"U.S. Department of Health and Human Services"},{"key":"10.1016\/j.jconrel.2025.114571_bb0125","series-title":"Guideline on Quality, Non-Clinical and Clinical Requirements for Investigational Advanced Therapy Medicinal Products (ATMPs) in Clinical Trials (EMA\/CAT\/22473\/2025)","author":"European Medicines Agency (EMA)","year":"2025"},{"key":"10.1016\/j.jconrel.2025.114571_bb0130","series-title":"Technical Guideline for Non-Clinical Pharmacokinetics Studies of Nanomedicines (Trial Implementation) [EB\/OL]","author":"National Medical Products Administration (NMPA, China)","year":"2025"},{"key":"10.1016\/j.jconrel.2025.114571_bb0135","series-title":"Technical Guideline for Non-Clinical Pharmacokinetics Studies of Liposomal Drug Products [EB\/OL]","author":"National Medical Products Administration (NMPA, China)","year":"2025"},{"issue":"39","key":"10.1016\/j.jconrel.2025.114571_bb0140","doi-asserted-by":"crossref","first-page":"12632","DOI":"10.1021\/jp1001786","article-title":"Thermodynamic and kinetic stability of DSPE-PEG(2000) micelles in the presence of bovine serum albumin","volume":"114","author":"Kastantin","year":"2010","journal-title":"J. Phys. Chem. B"},{"issue":"5","key":"10.1016\/j.jconrel.2025.114571_bb0145","doi-asserted-by":"crossref","first-page":"4976","DOI":"10.1021\/nn507130k","article-title":"Ultrasmall [64Cu]cu nanoclusters for targeting orthotopic lung Tumors using accurate positron emission tomography imaging","volume":"9","author":"Gao","year":"2015","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2025.114571_bb0150","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.jconrel.2024.01.016","article-title":"Polyethylene glycol (PEG) as a broad applicability marker for LC\u2013MS\/MS-based biodistribution analysis of nanomedicines","volume":"366","author":"Hyldbakk","year":"2024","journal-title":"J. Control. Release"},{"issue":"4","key":"10.1016\/j.jconrel.2025.114571_bb0155","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.apsb.2021.02.018","article-title":"The biological fate of the polymer nanocarrier material monomethoxy Poly(Ethylene Glycol)-Block-Poly(d,l-Lactic Acid) in Rat","volume":"11","author":"Meng","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"issue":"10","key":"10.1016\/j.jconrel.2025.114571_bb0160","doi-asserted-by":"crossref","first-page":"5193","DOI":"10.1021\/acs.analchem.6b04058","article-title":"Development and application of an MSALL-based approach for the quantitative analysis of linear polyethylene glycols in rat plasma by liquid chromatography triple-quadrupole\/time-of-flight mass spectrometry","volume":"89","author":"Zhou","year":"2017","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jconrel.2025.114571_bb0165","series-title":"Determination and Preclinical Pharmacokinetic Studies of Polyethylene Glycol by Q-TOF Mass Spectrometry","author":"Zhou","year":"2016"},{"issue":"10","key":"10.1016\/j.jconrel.2025.114571_bb0170","doi-asserted-by":"crossref","first-page":"e167","DOI":"10.1200\/JCO.2012.44.5767","article-title":"Pulmonary fibrosis after Pegylated liposomal doxorubicin in a patient with uterine papillary serous carcinoma","volume":"31","author":"Nevadunsky","year":"2013","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.jconrel.2025.114571_bb0175","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1007\/s12032-011-9893-0","article-title":"Interstitial pneumonitis induced by Pegylated liposomal doxorubicin in a patient with recurrent ovarian cancer","volume":"29","author":"Inaba","year":"2012","journal-title":"Med. Oncol."},{"key":"10.1016\/j.jconrel.2025.114571_bb0180","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/0006-3002(63)90792-3","article-title":"The substrate specificity of phospholipase a","volume":"70","author":"Van Deenen","year":"1963","journal-title":"Biochim. Biophys. Acta"},{"issue":"8","key":"10.1016\/j.jconrel.2025.114571_bb0185","doi-asserted-by":"crossref","first-page":"3146","DOI":"10.1002\/jps.22530","article-title":"Secretory phospholipase A2 responsive liposomes","volume":"100","author":"Zhu","year":"2011","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2025.114571_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.yrtph.2022.105242","article-title":"Setting impurity limits for endogenous substances: recommendations for a harmonized procedure and an example using fatty acids","volume":"134","author":"Jolly","year":"2022","journal-title":"Regul. Toxicol. Pharmacol."},{"issue":"2","key":"10.1016\/j.jconrel.2025.114571_bb0195","first-page":"500","article-title":"Biliary excretion of 400- to 1,000-d polyethylene glycol will influence the calculation of small intestinal absorption in portacaval-shunted rats","volume":"25","author":"Friman","year":"1997","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.jconrel.2025.114571_bb0200","article-title":"The absorption and excretion of a liquid polyethylene glycol","volume":"39","author":"Cb","year":"1950","journal-title":"J. Am. Pharm. Assoc. Am. Pharm. Assoc."},{"issue":"4","key":"10.1016\/j.jconrel.2025.114571_bb0205","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.krcp.2012.09.007","article-title":"Acute oxalate nephropathy caused by ethylene glycol poisoning","volume":"31","author":"Seo","year":"2012","journal-title":"Kidney Res. Clin. Pract."},{"issue":"9","key":"10.1016\/j.jconrel.2025.114571_bb0210","doi-asserted-by":"crossref","first-page":"475","DOI":"10.14740\/jmc4000","article-title":"Polyethylene glycol 3350 crystal nephropathy in association with glomerular mesangial immunoglobin a deposition","volume":"13","author":"Aly","year":"2022","journal-title":"J. Med. Cases"},{"issue":"3","key":"10.1016\/j.jconrel.2025.114571_bb0215","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/term.1688","article-title":"PEG hydrogel degradation and the role of the surrounding tissue environment","volume":"9","author":"Reid","year":"2015","journal-title":"J. Tissue Eng. Regen. Med."},{"key":"10.1016\/j.jconrel.2025.114571_bb0220","article-title":"Bacterial oxidation of polyethylene glycol","year":"2025","journal-title":"Appl. Environ. Microbiol."},{"issue":"5","key":"10.1016\/j.jconrel.2025.114571_bb0225","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/s00253-005-1936-z","article-title":"A novel Nicotinoprotein aldehyde dehydrogenase involved in polyethylene glycol degradation","volume":"68","author":"Ohta","year":"2005","journal-title":"Appl. Microbiol. Biotechnol."},{"issue":"12","key":"10.1016\/j.jconrel.2025.114571_bb0230","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1093\/clinchem\/28.12.2387","article-title":"Mixture analysis by triple-quadrupole mass spectrometry: metabolic profiling of urinary carboxylic acids","volume":"28","author":"Hunt","year":"1982","journal-title":"Clin. Chem."},{"key":"10.1016\/j.jconrel.2025.114571_bb0235","series-title":"Pharmacokinetic Study of mPEG2000 via IntravenousAdministration","author":"Xie","year":"2025"},{"key":"10.1016\/j.jconrel.2025.114571_bb0240","series-title":"Fate of Polyethylene Glycol 4000 in Vivo: A Full-Profile Study","author":"Tingting","year":"2025"},{"key":"10.1016\/j.jconrel.2025.114571_bb0245","series-title":"Biodegradation of Polyethers (Polyethylene Glycol, Polypropylene Glycol, Polytetramethylene Glycol, and Others)","author":"Kawai","year":"2005"},{"issue":"5","key":"10.1016\/j.jconrel.2025.114571_bb0250","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/j.immuni.2018.09.017","article-title":"Microbiota-derived lactate activates production of reactive oxygen species by the intestinal NADPH oxidase Nox and shortens Drosophila lifespan","volume":"49","author":"Iatsenko","year":"2018","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.jconrel.2025.114571_bb0255","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1292\/jvms.13-0329","article-title":"Screening for intestinal microflora influencing superoxide dismutase activity in mouse Cecal mucosa","volume":"76","author":"Dobashi","year":"2014","journal-title":"J. Vet. Med. Sci."},{"key":"10.1016\/j.jconrel.2025.114571_bb0260","series-title":"Pharmaceutical Sciences Encyclopedia","first-page":"1","article-title":"Impact of diseases, comorbidity, and target physiology on ADME, PK, and PK\/PD of therapeutic biologics","author":"Zheng","year":"2015"},{"key":"10.1016\/j.jconrel.2025.114571_bb0265","series-title":"ONIVYDE\u00ae (Irinotecan Liposome Injection)","year":"2015"},{"issue":"7","key":"10.1016\/j.jconrel.2025.114571_bb0270","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/0142-9612(90)90070-7","article-title":"Effect of cytochrome P-450 inhibition and stimulation on intensity of polyethylene degradation in microsomal fraction of mouse and rat livers","volume":"11","author":"Beranov\u00e1","year":"1990","journal-title":"Biomaterials"},{"issue":"1\u20132","key":"10.1016\/j.jconrel.2025.114571_bb0275","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.phymed.2004.06.022","article-title":"CYP3A4 and CYP2D6 inhibitory activities of Indonesian medicinal plants","volume":"13","author":"Usia","year":"2006","journal-title":"Phytomedicine"},{"issue":"19","key":"10.1016\/j.jconrel.2025.114571_bb0280","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1002\/rcm.1621","article-title":"Simultaneous determination of the inhibitory potency of herbal extracts on the activity of six major cytochrome P450 enzymes using liquid chromatography\/mass spectrometry and automated online extraction","volume":"18","author":"Unger","year":"2004","journal-title":"Rapid Commun. Mass Spectrom."},{"issue":"1","key":"10.1016\/j.jconrel.2025.114571_bb0285","doi-asserted-by":"crossref","first-page":"78","DOI":"10.3183\/npprj-2015-30-01-p078-091","article-title":"Structure formation of regenerated cellulose from its solution and resultant features of high wettability: a review","volume":"30","author":"Yamane","year":"2015","journal-title":"Nord. Pulp Pap. Res. J."},{"issue":"2","key":"10.1016\/j.jconrel.2025.114571_bb0290","doi-asserted-by":"crossref","first-page":"386","DOI":"10.3390\/pharmaceutics14020386","article-title":"Cellulose amphiphilic materials: chemistry, process and applications","volume":"14","author":"Zuppolini","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2025.114571_bb0295","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.jconrel.2020.12.047","article-title":"Anti-PEG scFv Corona ameliorates accelerated blood clearance phenomenon of PEGylated nanomedicines","volume":"330","author":"Zhang","year":"2021","journal-title":"J. Control. Release"},{"issue":"23","key":"10.1016\/j.jconrel.2025.114571_bb0300","doi-asserted-by":"crossref","first-page":"10107","DOI":"10.1021\/acs.nanolett.1c03946","article-title":"Facile separation of PEGylated liposomes enabled by anti-PEG scFv","volume":"21","author":"Tang","year":"2021","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2025.114571_bb0305","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2024.102255","article-title":"Reexamining in vivo fate of paclitaxel-loaded polymeric micelles","volume":"56","author":"Lin","year":"2024","journal-title":"Nano Today"},{"issue":"1","key":"10.1016\/j.jconrel.2025.114571_bb0310","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/ajco.13776","article-title":"Population pharmacokinetics of doxorubicin: a systematic review","volume":"19","author":"Methaneethorn","year":"2023","journal-title":"Asia Pac. J. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.jconrel.2025.114571_bb0315","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1021\/acs.bioconjchem.3c00174","article-title":"PEGylated lipid nanoparticle formulations: immunological safety and efficiency perspective","volume":"34","author":"Tenchov","year":"2023","journal-title":"Bioconjug. Chem."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016836592501185X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016836592501185X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T13:23:15Z","timestamp":1781702595000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016836592501185X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":62,"alternative-id":["S016836592501185X"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.114571","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Deciphering the in vivo fate and biomacromolecular interactions of DSPE-PEG2000","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.114571","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"114571"}}